הפודקאסטים הטובים ביותר ב-CCO (2025)

1
Evaluating and Managing PBC Symptoms: Curbside Consults Podcast 18:43

3d ago18:43

18:43

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include: Strategies and tools for assessing pruritus Nonpharmacologic and pharmacologic management of pruritus Secon…

1
Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer 45:08

7d ago45:08

45:08

In this episode, Jame Abraham, MD, FACP; William J. Gradishar, MD, FACP, FASCO; and Laura Spring, MD, review key insights and frequently asked questions related to the CDK4/6 inhibitors used to treat patients with early and metastatic hormone receptor (HR)–positive/HER2-negative breast cancer from a live program held in January 2025. Key clinical p…

1
COVID-19 in the EU: Inpatient Treatment of Mild to Moderate COVID-19 in Patients Who Are Immunocompromised 13:27

21d ago13:27

13:27

In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including: Initial workup, which may include laboratory tests and/or imaging Latest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, incl…

1
Liberal Arts in the Age of AI: The CCO's Unexpected Advantage 7:12

22d ago7:12

7:12

Introducing The New CCO: Brief, a shorter format podcast from Page. In this episode, we look to uncover the most powerful weapon in modern communications today. Spoiler: it isn't artificial intelligence—it's the distinctly human ability to draw insights from art, philosophy and science. Listen to find out why your liberal arts degree might just be …

1
Defining Nonresponse to PBC Treatment: Curbside Consults Podcast 18:55

3d ago18:55

18:55

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including: How and when to measure treatment response Evidence-based goals of therapy Considerations for second-line treatment N…

1
The Health Impacts of Physically Demanding Work 13:16

13d ago13:16

13:16

Do physically active occupations make for healthier workers? Not necessarily. In this episode, Dr. Avi Biswas, scientist at the Institute for Work and Health, shares recommendations for safe, practical physical activity designed to meet the diverse needs of workers.

1
PBC Perspectives: A Patient and HCP in Conversation 27:29

14d ago27:29

27:29

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss: The chronic nature of PBC Going beyond biochemical markers to assess and address symptoms such as fatigue and pr…

1
Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma: Key Updates From the Annual Hematology Meeting 20:01

18d ago20:01

20:01

In this episode, Shaji K. Kumar, MD, reviews key data on bispecific antibodies used to treat patients with relapsed/refractory multiple myeloma recently presented at the 2024 annual American Society of Hematology meeting, including: Early results with teclistamab combined with anti-CD38 therapy Real-world data with teclistamab including its use aft…

1
Defining Best Practices in HBV Care 34:14

22d ago34:14

34:14

In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss best practices in hepatitis B virus (HBV) care, including: 2023 CDC HBV screening recommendations Summary of guideline recommendations for hepatitis delta virus (HDV) screening Use of HDV reflex testing to…

1
COVID-19 in the EU: Current Trends and Risk Factors for Severe COVID-19 Progression 16:48

22d ago16:48

16:48

In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss: Current SARS-CoV-2 trends in the EU Risk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system status Factors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignan…

1
Expert Guidance on Managing Axial Spondyloarthritis and Psoriatic Arthritis to Improve Patient Outcomes and Quality of Life 27:38

29d ago27:38

27:38

Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including: The current treatment landscape (eg, small molecules, biologics) Risk factors to consider when prescribing JAK inhibitors Key consi…

1
Building Trust in a Globalized World: Data, AI and Human Connection 28:21

1M ago28:21

28:21

In a world of increasing complexity, building trust across cultures has never been more challenging—or essential. Shahar Silbershatz and Axel Löber share insights on how global CCOs can navigate cultural nuances, leverage AI and data and foster authentic stakeholder connections. Listen to the conversation to hear how human connection remains at the…

1
Consommation de substances, stigmatisation et dépendance chez les hommes travaillant dans des métiers spécialisés 15:14

2M ago15:14

15:14

La stigmatisation à l’égard de la consommation de substances influe sur la façon dont nous parlons aux personnes, sur les politiques que nous élaborons et sur la prestation des soins. Dans cet épisode, la Dre Theresa Tam, administratrice en chef de la santé publique du Canada, et Anne Tennier, présidente et première dirigeante du CCHST, discutent d…

1
Substance Use, Stigma and Addiction Among Men in Trades 12:27

2M ago12:27

12:27

Stigma surrounding substance use affects how we talk to individuals, the policies we develop, and how we provide care. In this episode, Dr. Theresa Tam, Chief Public Health Officer of Canada, and Anne Tennier, President and CEO of CCOHS, discuss ways we can reduce stigma and support men in the trades who are struggling.…

1
Clinical Highlights: Oral SERDs for Patients With HR+/HER2- ESR1-Mutated Advanced Breast Cancer 36:04

2M ago36:04

36:04

In this episode, listen to Virginia Kaklamani, MD, DSc; Erica L. Mayer, MD, MPH; and Laura M. Spring, MD, share their clinical insights and takeaways from a live symposium, including from key abstracts presented at the 2024 San Antonio Breast Cancer Symposium: Estrogen receptor mutations in patients With HR-positive/HER2-negative advanced breast ca…

1
Simplified HCV Care in Sexual and Reproductive Health Clinics 1:04:44

2M ago1:04:44

1:04:44

In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including: HCV disease burden in the United States Screening recommendations Strategies to overcome barriers to HCV screening Treatment recommendations, inc…

1
Key PBC Studies From AASLD 2024 20:16

2M ago20:16

20:16

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …

1
Key PBC Studies From AASLD 2024 20:16

2M ago20:16

20:16

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including: ELATIVE, a phase III trial of elafibranor for PBC RESPONSE, a phase III trial of seladelpar for PBC ASSURE, another phase III trial of seladelpar for PBC Presenter: Sonal Kumar, MD, MPH Director, Clinical …

1
Understanding Current Trends and Risk Factors for Progression to Severe COVID-19 16:01

2M ago16:01

16:01

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include: How to complete a co…

1
Simplified HCV Screening and Care in People Who Use Drugs 1:08:21

2M ago1:08:21

1:08:21

In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics: Screening recommendations Strategies to improve HCV screening HCV testing Treatment goals Strategies to improve HCV tr…

1
Inpatient Treatment for Mild to Moderate COVID-19 16:01

2M ago16:01

16:01

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including: Current guidelines from the Infectious Diseases Society of America and National Institutes of Health How to optimize therapy selection based on patien…

1
Emerging Therapies for Pruritus in PBC 23:34

2M ago23:34

23:34

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patien…

1
Emerging Therapies for Pruritus in PBC 23:34

2M ago23:34

23:34

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patien…

1
Clinical Management of Pruritus in PBC 21:18

2M ago21:18

21:18

Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Prur…

1
Clinical Management of Pruritus in PBC 21:18

2M ago21:18

21:18

Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including: Prur…

1
Living With Pruritus in PBC: A Patient Perspective 12:19

2M ago12:19

12:19

In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine …

1
Living With Pruritus in PBC: A Patient Perspective 12:19

2M ago12:19

12:19

In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective. Presenters: Marlyn J. Mayo, MD Professor of Internal Medicine …

1
CCO Independent Conference Coverage of IDWeek and Glasgow 2024 49:28

2M ago49:28

49:28

In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including: PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC TRIO Health Cohort and OPERA e…

1
Recent Advances in PBC Management 8:46

3M ago8:46

8:46

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Pr…

1
Recent Advances in PBC Management 8:46

3M ago8:46

8:46

In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including: Treatment goals Use of PPAR agonists for the treatment of PBC Clinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO) Presenter: Christopher L. Bowlus, MD Lena Valente Pr…

1
Les principales questions sur la santé et la sécurité de 2024 5:54

3M ago5:54

5:54

Chaque année, le CCHST reçoit des questions sur la santé et la sécurité de tout le Canada. Nous discutons avec l’un de nos spécialistes techniques des questions les plus importantes et les plus fréquentes de l’année.על ידי CCOHS

1
Top Health and Safety Questions of 2024 5:38

3M ago5:38

5:38

It’s the year end roundup you’ve been waiting for: the top health and safety questions you asked us in 2024.על ידי CCOHS

1
Reaching Patients Where They Are: Experience With LAI Antipsychotics in Community Practice 32:10

3M ago32:10

32:10

In this episode, Dr Robert Cotes and Dr David Goldsmith discuss their clinical experience with long-acting injectable antipsychotic treatments in the Grady Health System, with a focus on communication strategies to educate patients on their treatment options and engage them in shared decision-making. Presenters: Robert O. Cotes, MD, DFAPA Associate…

1
From Efficiency to Impact: How GenAI is Transforming Communications Strategy 34:59

3M ago34:59

34:59

Generative AI is evolving from a simple productivity booster to a strategic game-changer in communications. At the Page Up Annual Conference in October, member Ethan McCarty moderated a dynamic panel featuring Joao Belo of Takeda Pharmaceuticals, April Yue of Boston University, and Dan Gaynor of Signal AI. Together, they explored how to leverage AI…

1
Prevent Slips, Trips and Falls with Good Workplace Housekeeping 4:24

3M ago4:24

4:24

Good workplace housekeeping might seem like a simple concept, but it doesn’t always get the respect it deserves. Learn how effective housekeeping can reduce the risk of slips, trips and falls, one of the most common lost-time injuries.על ידי CCOHS

1
Prévenir les glissades, trébuchements et chutes grâce à une bonne tenue des locaux de travail 6:05

3M ago6:05

6:05

La bonne tenue des locaux de travail peut sembler un concept simple, mais elle n’est pas toujours reconnue à sa juste valeur. Découvrez comment une tenue efficace des locaux peut réduire le risque de glissades, de trébuchements et de chutes, qui sont à l’origine de blessures entraînant une absence au travail parmi les plus courantes.…

1
Be an Ally: Navigating the Healthcare System as a Transgender Individual With HIV 32:05

4M ago32:05

32:05

In this episode, a transfemme nonbinary individual living with HIV shares her experience navigating the healthcare system, alongside her infectious disease physician, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS. Hear them discuss key considerations when caring for gender-diverse individuals, including: Understanding how people are more than j…

1
Navigating Sjogren's Syndrome: Guiding Patients in Their Care Journey 24:11

4M ago24:11

24:11

Listen as Elizabeth Kircher, DNP, and R. Hal Scofield, MD, discuss best practice approaches for the treatment of Sjögren’s syndrome and what’s on the horizon for future therapeutic options. Topics include: Challenges in Sjogren’s Syndrome Diagnosis and Patient Understanding: Difficulties in explaining Sjogren’s syndrome diagnosis to patients unfami…

1
Key HIV Studies Influencing My Practice Following HIVR4P 2024—Drs . Linda-Gail Bekker and Meredith Clement 46:26

4M ago46:26

46:26

In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including: Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudy Implementing in…

1
Be an HPV Vaccine Champion: Reaching Underserved Populations 26:10

4M ago26:10

26:10

Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to achieve health equity in HPV vaccination, including: Trends among males vs females Messaging considerations for those from diverse populations (eg, LGTBQ+ and rural communities) How healthcare professionals can address barriers to care Then, hear answers fr…

1
Strategies to Improve HPV Vaccine Uptake: Effective Vaccine Messaging 13:35

4M ago13:35

13:35

Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to improve your messaging techniques with the HPV vaccine, including: Persisting in vaccine recommendation after initial refusal Educating patients and their families together Ensuring staff are trained to correctly answer questions Knowing when interested pat…

1
The True Burden of HPV Infection 16:45

4M ago16:45

16:45

Listen in as Sharon G. Humiston, MD, MPH, discusses current trends in HPV, including: Incidence and prevalence trends in the US Sex-related features of HPV-attributable cancers How HPV vaccination uptake can prevent certain types of cancer Current guidelines and recommendations for HPV vaccination Presenter: Sharon G. Humiston, MD, MPH Director for…

1
Barbie Unboxed: Behind the Scenes of Mattel’s First Foray into Feature Films with EVP of Corp Comms, Catherine Frymark 28:59

4M ago28:59

28:59

Following our interview with the 2024 Page and IPR Case Study Competition winners, we bring you an extended conversation between the students and Katherine Frymark, EVP of Corporate Communications at Mattel, getting an insider perspective on the success behind Barbie’s brand transformation. The insightful conversation, led by IPR President Tina McC…

1
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies 20:40

4M ago20:40

20:40

In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including: 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D The role of bispecific antibodies in R/R MM Safety considerations for patients while receiving a bispecific antibody Emerging…

1
Before and After the Polls Close, Bruce Mehlman at Page Annual 47:56

4M ago47:56

47:56

While the outcome of this unusual election cycle is uncertain, one thing is clear: CCOs will be treading carefully between two political minefields. At our recent Annual Conference, Bruce Mehlman, a renowned expert on the intersection of business, politics and technology, delivered a compelling session on the key drivers of today’s political climat…

פודקאסטים ששווה להאזין

פודקאסטים בנושא CCO

פודקאסטים ששווה להאזין

מדריך עזר מהיר